MP50: Penile and Testicular Cancer II

Poster Session Moderator(s)

• TM

  Timothy Masterson, MD (he/him/his)

  Professor of Urology
  Indiana University School of Medicine
• 

  Richard Matulewicz, MD

  Assistant Professor
  Memorial Sloan Kettering Cancer Center
• 

  Philippe Spiess, MD (he/him/his)

  Professor, Department of Urology
  Moffitt Cancer Center

Presentations:

• 7:00 AM – 9:00 AM CST

  MP50-01: Validation of AGR2 and KRT19 as specific proteins being significantly and differentially expressed in teratoma compared to necrosis in retroperitoneal lymph node resections after chemotherapy (pcRPLND)
  

  Poster Presenter: Tim Nestler, MD
• 7:00 AM – 9:00 AM CST

  MP50-02: Risk of local recurrence in men with penile intraepithelial neoplasia (PeIN) in the surgical margin after penile sparing surgery
  

  Poster Presenter: Luca Antonelli, MD (he/him/his)
• 7:00 AM – 9:00 AM CST

  MP50-03: [⁶⁸Ga]Ga-FAPI-46 PET/CT prior to surgery in squamous penile cancer – preliminary clinical results
  

  Poster Presenter: Lennert Eismann, MD
• 7:00 AM – 9:00 AM CST

  MP50-04: Overall survival in penile cancer: analysis of a large contemporary cohort treated at a tertiary referral centre
  

  Poster Presenter: James Churchill, MBBS (he/him/his)
• 7:00 AM – 9:00 AM CST

  MP50-05: Predictive factors of testicular cancer in small testicular tumors treated with partial orchiectomy: a retrospective study.
  

  Poster Presenter: Jonathan Olivier, MD, PHD (he/him/his) – CHU De Lille
• 7:00 AM – 9:00 AM CST

  MP50-06: Survival of testicular pure teratoma vs. mixed germ cell tumor patients across all stages
  

  Poster Presenter: Cristina Cano Garcia, MD (she/her/hers) – University Hospital Frankfurt
• 7:00 AM – 9:00 AM CST

  MP50-07: Contemporary Short-Term Outcomes for Open Virgin Retroperitoneal Lymph Node Dissection
  

  Poster Presenter: Jacob Daniel McFadden, MD (he/him/his)
• 7:00 AM – 9:00 AM CST

  MP50-08: Post-chemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) for Seminoma: Is surgery effective?
  

  Poster Presenter: Isamu Tachibana, MD – University of Texas Southwestern
• 7:00 AM – 9:00 AM CST

  MP50-09: Contemporary Outcomes of Primary Extraperitoneal Retroperitoneal Lymph Node Dissection for Stage II Germ Cell Tumors
  

  Poster Presenter: Muhannad Alsyouf, MD – Loma Linda University
• 7:00 AM – 9:00 AM CST

  MP50-10: Evaluation and risk factor analysis of complications of inguinal lymph node dissection in a large multi-disciplinary cohort
  

  Poster Presenter: Manon Theodora Anna Vreeburg (she/her/hers)
• 7:00 AM – 9:00 AM CST

  MP50-11: Integrative Multi-omics Profiling in Penile Squamous Cell Carcinoma
  

  Poster Presenter: Timothy Shaw, PHD – H Lee Moffitt Cancer Center
• 7:00 AM – 9:00 AM CST

  MP50-12: Clinicopathologic Analysis and Digital Evaluation of Orchiectomy Specimens in Patients with Gender Dysphoria
  

  Poster Presenter: Ivan De La Riva- Morales, MD (he/him/his)
• 7:00 AM – 9:00 AM CST

  MP50-13: Open versus minimal invasive retroperitoneal lymph node dissection: a National Cancer Database analysis
  

  Poster Presenter: Harshit Garg, MD, M.Ch (he/him/his)
• 7:00 AM – 9:00 AM CST

  MP50-14: A Multicenter Evaluation of the Prognostic Utility of Changes in Treatment-Associated Body Composition in Men with Germ Cell Tumors (GCT) of the Testis: Implications for Adverse Events and Complications
  

  Poster Presenter: Claire Marie Buxton, BS (she/her/hers)
• 7:00 AM – 9:00 AM CST

  MP50-15: Testicular radiomics correlated with pathology at time of post-chemotherapy retroperitoneal lymph node dissection for non-seminomatous germ cell tumor.
  

  Poster Presenter: Nikit Venishetty, BA
• 7:00 AM – 9:00 AM CST

  MP50-16: Oncological Outcomes Following Robotic Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Testicular Cancer: A Worldwide Multicenter Study
  

  Poster Presenter: Alireza Ghoreifi, MD (he/him/his) – Duke University